The board of directors of Baxter International Inc (NYSE:BAX) declared a quarterly dividend of USD0.22 per share of the company's common stock, it disclosed on Tuesday.
This cash dividend will be paid on 1 October 2019 to shareholders of record as of 30 August 2019.
Annually, the dividend rate is equivalent t0 USD0.88 per share of common stock, according to the company.
With products, technologies and therapies available in 100 countries, Baxter's portfolio consist of critical care, nutrition, renal, hospital as well as surgical products.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government